Nucleus Network MSP: A global leader in renal clinical trials

Renal impairment trials demand precision, speed, and a deep understanding of the patient population. For more than 20 years, sponsors have trusted Nucleus Network to deliver all three. Backed by a dedicated team, tailored infrastructure, and a participant-first approach.

Our renal program, led by Dr. Trisha Shamp in Minneapolis, is built for excellence across all impairment levels, including end-stage renal disease (ESRD). With over 1,000 pre-screened renal patients, onsite hemodialysis, and expert medical oversight, we help sponsors reach key milestones faster and with confidence.

At Nucleus Network, our site in Minneapolis has become a benchmark for early-phase renal impairment studies, known for speed, reliability, and unmatched attention to detail.